- Top NIH official, Fauci adviser admits hiding emails regarding COVID origins
- One-fourth of 40-year-olds in the US have never been married.
- What’s wrong with price transparency? It’s tied to insurance billing codes instead of meaningful bundles of services patients can understand.
- Reason for more wealth inequality: longer life spans. (WSJ)
- Study: estimated cost of CMS delay in approving the new Alzheimer’s drug: $13.1 billion to $545.6 billion.
- Does cold immersion therapy really work? Probably not.
Category: Cost of Healthcare
Update on Amazon’s Health Care Initiative: A Mixed Bag, Both Convenient and Convoluted
A reporter for Health Care News emailed me asking about Amazon’s health care initiative so I decided to take another look. Earlier this year I wrote about Amazon entering the health care space. One Medical is its membership-based medical service. One Medical features virtual clinical visits along with 125+ physical locations in 25 cities. It claims to break the mold for…
Primary Care Physicians’ Changing Relationship with Patients
Does your doctor recognize you when you come in? Or does he or she merely scan your file quickly before stepping into the exam room? My dog’s veterinarian knows her history mostly from memory, but I’m not convinced physicians in large cities can have that close a relationship with their patients. It’s a little too much to expect that level of relationship in my opinion. It isn’t necessarily bad if our doctors only remember us contextually. That is, at the office they remember our history when prompted with a file but would not recognize us at the mall without a prompt.
Thursday Links
- Of the 7.5 million people who bought their first firearm during the pandemic, half were women, and nearly half were people of color.
- More than $200 billion (17%) of small business Covid relief lost to fraud.
- Is pickle ball too noisy?
- College tuition explained: it’s price discrimination.
- GOP Senators: “We were shocked to see the Food and Drug Administration (FDA) announce via a tweet that the Administration has ‘taken steps for temporary importation of certain foreign-approved versions of cisplatin products’ – meaning from China – without otherwise informing American oncologists.”